Severe Pancytopenia Induced by Low-dose Methotrexate in a Hemodialysis Patient
| dc.contributor.author | Yigit, Irem Pembegul | |
| dc.contributor.author | Ulu, Ramazan | |
| dc.contributor.author | Yildiz, Yener | |
| dc.contributor.author | Dogukan, Ayhan | |
| dc.contributor.author | Celiker, Hueyin | |
| dc.date.accessioned | 2026-08-12T17:01:15Z | |
| dc.date.issued | 2010 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Methotrexate has been used as an important alternative therapy in the treatment of various rheumatic diseases. It is primarily cleared by the kidney. Life-threatening marrow suppression in hemodialysis patients has been reported. A 35-year-old woman undergoing hemodialysis developed severe stomatitis and pancytopenia after low-dose methotrexate treatment for rheumatoid arthritis. She recovered after folinic acid, granulocyte colony-stimulating factor, antibiotic and daily hemodialysis therapy. | |
| dc.identifier.doi | 10.5262/tndt.2010.1002.75 | |
| dc.identifier.endpage | 149 | |
| dc.identifier.issn | 1300-7718 | |
| dc.identifier.issue | 2 | |
| dc.identifier.startpage | 147 | |
| dc.identifier.uri | https://doi.org/10.5262/tndt.2010.1002.75 | |
| dc.identifier.uri | https://hdl.handle.net/11508/47614 | |
| dc.identifier.volume | 19 | |
| dc.identifier.wos | WOS:000217173200015 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | tr | |
| dc.publisher | Turk Nefroloji Diyaliz Transplantasyon Dergisi | |
| dc.relation.ispartof | Turkish Nephrology Dialysis and Transplantation Journal | |
| dc.relation.publicationcategory | Diğer | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | Methotrexate | |
| dc.subject | Hemodialysis | |
| dc.subject | Pancytopenia | |
| dc.title | Severe Pancytopenia Induced by Low-dose Methotrexate in a Hemodialysis Patient | |
| dc.type | Editorial |
